Mannkind (MNKD) Gross Margin (2016 - 2026)

Mannkind (MNKD) posted quarterly Gross Margin of 91.67% for Q1 2026, down 352.0% year-over-year from 36.38% in Q1 2025, and up 4.7% quarter-over-quarter from 87.56% in Q4 2025.

Mannkind (MNKD) Gross Margin (2016 - 2026) Analysis & Trends

Mannkind (MNKD) has reported Gross Margin for 11 consecutive years, with 91.67% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Gross Margin fell 352.0% year-over-year to 91.67%; the TTM figure through Mar 2026 stood at 91.53% (down 263.0% YoY), while the FY2025 annual figure was 92.32%, down 158.0% from the prior year.
  • Gross Margin rose to 91.67% in Q1 2026 per MNKD's latest filing, from 87.56% in the prior quarter.
  • Across five years, Gross Margin topped out at 134.01% in Q4 2023 and bottomed at 6.14% in Q1 2022.
  • Historically, Gross Margin has averaged 81.14% across 5 years, with a median of 91.67% in 2026.
  • On a YoY basis, Gross Margin climbed as much as 25229 bps in 2022 and fell as far as 8139 bps in 2022.
  • Mannkind's Gross Margin stood at 88.68% in 2022, then jumped by 51 bps to 134.01% in 2023, then sank by 30 bps to 93.74% in 2024, then decreased by 7 bps to 87.56% in 2025, then grew by 5 bps to 91.67% in 2026.
  • Business Quant data shows MNKD's Gross Margin at 91.67% in Q1 2026, 87.56% in Q4 2025, and 94.52% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 85.33%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 91.59%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 90.68%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 89.76%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 60,631,834.75%
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 76.90%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 84.20%
10 Mannkind 1.19 Bn 1.08 Bn 94.97 Mn 86.83%

Historic Data

Download Data
DateValue
Jun 30, 2026 86.83%
Mar 31, 2026 91.67%
Dec 31, 2025 87.56%
Sep 30, 2025 94.52%
Jun 30, 2025 93.98%
Mar 31, 2025 95.19%
Dec 31, 2024 93.74%
Sep 30, 2024 95.44%
Jun 30, 2024 92.26%
Mar 31, 2024 94.24%
Dec 31, 2023 134.01%
Sep 30, 2023 73.78%
Jun 30, 2023 89.25%
Mar 31, 2023 86.39%
Dec 31, 2022 88.68%
Sep 30, 2022 58.75%
Jun 30, 2022 16.02%
Mar 31, 2022 -6.14%
Dec 31, 2021 -163.60%
Sep 30, 2021 82.84%